Parallel Profile

Create a vendor selection project & run comparison reports
Click to express your interest in this report
Indication of coverage against your requirements
A subscription is required to activate this feature. Contact us for more info.
Celent have reviewed this profile and believe it to be accurate.


Parallel Profile matches medications to each individual’s DNA improving health outcomes and decreasing both pharmacy and hospital costs. Serious adverse drug reactions (ADRs) are common causes of ER visits, expensive hospital admissions, longer lengths of stay, readmissions, and high cost and catastrophic claims. Because of ADRs 2.7 million Americans are admitted inpatient every year and 128,000 die—that’s 3 times as many people as die from breast cancer each year. Parallel prevents ADRs by providing at risk members (on 4+ drugs, on a dangerous or expensive drug, in a chronic care or behavioral health management program) with access to a secure platform to order a confidential pharmacogenetic test and then an app that allows them to check current and new prescription and over the counter medications to instantly see if their genetics impact the safety and/or efficacy of that drug as well as identify interaction risks.If the drug is suboptimal, alternatives are provided.When integrated with the PBM, the lowest cost alternatives are highlighted.If the individual does not have an optimal option in the lowest co-pay level, an auto edit at the register assures they won’t be financially incented to take a problem drug.